Ignite Creation Date:
2025-12-25 @ 2:29 AM
Ignite Modification Date:
2026-03-09 @ 2:45 AM
Study NCT ID:
NCT03788434
Status:
COMPLETED
Last Update Posted:
2023-07-03
First Post:
2018-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Sponsor:
Vedanta Biosciences, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-08
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-15
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-19
First Submit QC Date:
None
Study First Post Date:
2018-12-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-08-29
Results First Submit QC Date:
None
Results First Post Date:
2023-07-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-29
Last Update Post Date:
2023-07-03
Last Update Post Date Type:
ACTUAL